The Second Trump White House Could Drastically Reshape Infectious Disease Research. Here’s What’s at Stake.
The Second Trump White House Could Drastically Reshape Infectious Disease Research. Here’s What’s at Stake.

www.propublica.org
The Second Trump White House Could Drastically Reshape Infectious Disease Research. Here’s What’s at Stake.

Reshape sorta implies the same volume. Our government research will be outsourced to the highest bidder. RFK has already silently shifted away from big pharma talking points to anti-scientist and grant talking points. Much like the entire cabinet and Trump himself, any and all previous emotional boogeymen will be quickly replaced by the working class as talk becomes actions. What else would you expect from a gaggle of billionaires currently surveying their new investment.